OnKure Therapeutics (OKUR) Financials

Balance sheets

Sep 30, 2024Jun 1, 2024Mar 1, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023

Total Assets

$77.6 M(+204.8%)$25.5 M(+3.9%)$24.5 M(-31.4%)$35.7 M---

Current Assets

$77.0 M(+223.6%)$23.8 M(+4.8%)$22.7 M(-32.8%)$33.8 M---

Non Current Assets

$646.0 K(-61.5%)$1.7 M(-7.8%)$1.8 M(-7.6%)$2.0 M---

Total Liabilities

$3.6 M(-97.6%)$149.1 M(+9.8%)$135.8 M(-1.3%)$137.6 M---

Current Liabilities

$3.2 M(-75.0%)$13.0 M(+133.9%)$5.6 M(-23.8%)$7.3 M---

Long Term Liabilities

$379.0 K(-99.7%)$136.1 M(+4.5%)$130.2 M(-0.0%)$130.3 M---

Shareholders Equity

$74.0 M(+159.9%)-$123.6 M(-11.1%)-$111.3 M(-9.3%)-$101.8 M---

Book Value

$74.0 M(+159.9%)-$123.6 M(-11.1%)-$111.3 M(-9.3%)-$101.8 M---

Working Capital

$73.8 M(+582.1%)$10.8 M(-37.0%)$17.2 M(-35.2%)$26.5 M---

Cash And Cash Equivalents

$60.7 M(+225.7%)$18.6 M(-3.2%)$19.2 M(-35.6%)$29.9 M---

Accounts Payable

$237.0 K(-97.1%)$8.3 M(+128.0%)$3.6 M(+6.0%)$3.4 M---

Accounts Receivable

-------

Short Term Debt

-$216.0 K(+1.9%)$212.0 K----

Long Term Debt

$379.0 K(-93.9%)$6.2 M(+1408.5%)$412.0 K(-11.6%)$466.0 K---

Total Debt

$665.0 K(-89.7%)$6.4 M(+930.6%)$624.0 K(-7.4%)$674.0 K-$0.0(0%)$0.0

Debt To Equity

0.0(+120.0%)-0.1(-400.0%)-0.0(0%)-0.0---

Current Ratio

23.7(+1195.6%)1.8(-55.3%)4.1(-11.8%)4.6---

Quick Ratio

-------

Inventory

-------

Retained Earnings

-$236.0 M(-87.7%)-$125.7 M(-12.7%)-$111.6 M(-9.3%)-$102.1 M---

PB Ratio

-------

Income statements

Sep 30, 2024Jun 1, 2024Mar 1, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023

EPS

-$0.3(-168.2%)-$0.1(-48.3%)-$0.1--$1.4(-2310.4%)-$0.1(+5.7%)-$0.1

TTM EPS

-$0.4(+72.1%)-$1.6(-2.8%)-$1.6--$1.6(-1169.9%)-$0.1(-94.3%)-$0.1

Revenue

$0.0--$0.0(0%)$0.0--

TTM Revenue

$0.0--$0.0(0%)$0.0--

Total Expenses

$4.7 M(-67.5%)$14.3 M(+45.9%)$9.8 M(+146.6%)-$21.1 M(-201.1%)$20.9 M(+141.9%)$8.6 M(-1.4%)$8.8 M

Operating Expenses

$4.7 M(-67.5%)$14.3 M(+45.9%)$9.8 M(+146.6%)-$21.1 M(-201.1%)$20.9 M(+141.9%)$8.6 M(-1.4%)$8.8 M

Cost Of Goods Sold

-------

TTM Cost Of Goods Sold

-------

Gross Profit

-------

TTM Gross Profit

-------

Gross Margin

-------

Operating Profit

-$4.7 M(+67.5%)-$14.3 M(-45.9%)-$9.8 M(-146.6%)$21.1 M(+201.1%)-$20.9 M(-141.9%)-$8.6 M(+1.4%)-$8.8 M

TTM Operating Profit

-$7.7 M(+67.7%)-$23.9 M(-31.3%)-$18.2 M(-6.3%)-$17.2 M(+55.2%)-$38.3 M(-120.1%)-$17.4 M(-98.7%)-$8.8 M

Operating Margin

-------

Net Income

-$3.7 M(+73.9%)-$14.1 M(-48.3%)-$9.5 M(-151.5%)$18.5 M(+196.5%)-$19.2 M(-134.6%)-$8.2 M(+5.7%)-$8.7 M

TTM Net Income

-$8.8 M(+63.7%)-$24.3 M(-32.4%)-$18.4 M(-4.9%)-$17.5 M(+51.4%)-$36.1 M(-113.8%)-$16.9 M(-94.3%)-$8.7 M

Net Margin

-------

EBIT

-$4.7 M(+67.0%)-$14.1 M(-43.6%)-$9.8 M(-146.6%)$21.1 M(+201.1%)-$20.9 M(-155.3%)-$8.2 M(+6.5%)-$8.8 M

TTM EBIT

-$7.5 M(+68.4%)-$23.7 M(-33.3%)-$17.8 M(-6.5%)-$16.7 M(+55.8%)-$37.8 M(-123.3%)-$16.9 M(-93.5%)-$8.8 M

EBITDA

-$4.7 M(+66.6%)-$14.0 M(-44.3%)-$9.7 M(-144.9%)$21.5 M(+203.2%)-$20.9 M(-160.2%)-$8.0 M(+6.9%)-$8.6 M

TTM EBITDA

-$6.8 M(+70.6%)-$23.0 M(-34.8%)-$17.0 M(-6.6%)-$16.0 M(+57.4%)-$37.5 M(-125.4%)-$16.7 M(-93.1%)-$8.6 M

Selling, General & Administrative Expenses

$3.8 M(+4.7%)$3.6 M(+183.9%)$1.3 M(+108.9%)-$14.2 M(-295.7%)$7.3 M(+548.8%)$1.1 M(-8.9%)$1.2 M

TTM SGA

-$5.6 M(-167.2%)-$2.1 M(+54.1%)-$4.6 M(+0.8%)-$4.6 M(-147.9%)$9.6 M(+309.3%)$2.3 M(+91.1%)$1.2 M

Depreciation And Amortization

-$259.0 K(-275.0%)$148.0 K(-2.0%)$151.0 K(-65.2%)$434.0 K(+376.4%)-$157.0 K(-201.3%)$155.0 K(+21.1%)$128.0 K

TTM D&A

$474.0 K(-17.7%)$576.0 K(-1.2%)$583.0 K(+4.1%)$560.0 K(+344.4%)$126.0 K(-55.5%)$283.0 K(+121.1%)$128.0 K

Interest Expense

-$26.0 K---$0.0-

TTM Interest Expense

-$26.0 K---$0.0-

Income Tax

-------

TTM Income Tax

-------

PE Ratio

-------

PS Ratio

-------

Cashflow statements

Sep 30, 2024Jun 1, 2024Mar 1, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023

Cash From Operations

-$13.0 M(-100.8%)-$6.5 M(+39.1%)-$10.6 M(-213.3%)$9.4 M(+133.2%)-$28.3 M(-155.0%)-$11.1 M(-143.6%)-$4.6 M

TTM CFO

-$20.7 M(+42.5%)-$36.0 M(+11.4%)-$40.6 M(-17.6%)-$34.5 M(+21.4%)-$43.9 M(-180.8%)-$15.6 M(-243.6%)-$4.6 M

Cash From Investing

$61.3 M(+612770.0%)-$10.0 K(-11.1%)-$9000.0(-100.0%)$29.0 M(+199.4%)-$29.2 M(-48538.3%)-$60.0 K(-445.4%)-$11.0 K

TTM CFI

$90.3 M(+46623.7%)-$194.0 K(+20.5%)-$244.0 K(+0.8%)-$246.0 K(+99.2%)-$29.3 M(-41102.8%)-$71.0 K(-545.5%)-$11.0 K

Cash From Financing

-$4.0 M(-167.6%)$5.9 M(+58580.0%)$10.0 K(+100.1%)-$11.9 M(-199.8%)$11.9 M(+594450.0%)-$2000.0(-100.0%)$53.1 M

TTM CFF

-$10.0 M(-268.9%)$5.9 M(+21740.7%)$27.0 K(-100.0%)$53.1 M(-18.3%)$65.0 M(+22.4%)$53.1 M(0%)$53.1 M

Free Cash Flow

-$13.0 M(-100.3%)-$6.5 M(+39.1%)-$10.6 M(-214.0%)$9.3 M(+132.8%)-$28.4 M(-154.7%)-$11.2 M(-144.4%)-$4.6 M

TTM FCF

-$20.8 M(+42.6%)-$36.2 M(+11.4%)-$40.9 M(-17.5%)-$34.8 M(+21.1%)-$44.1 M(-180.8%)-$15.7 M(-244.4%)-$4.6 M

CAPEX

---$50.0 K(-60.0%)$125.0 K--

TTM CAPEX

---$175.0 K(+40.0%)$125.0 K--

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------